AUSTRALIAN CLINICAL LABS LIMITED
ASX:ACLHealth Care Equipment & ServicesToday’s holders own 98.4% of what they think they own, once every option and right converts.
No issuance filings since 2024; no dilution pressure signals in current disclosures
No ordinary share count change for AUSTRALIAN CLINICAL LABS LIMITED is available on record between January 2024 and the present, as no share-issuance filings (Appendix 2A) have been lodged in that period. The company has not undertaken any capital raises in the past 24 months. Options and rights on issue could convert into 3M new shares, representing 1.6% of the current share count, of which none are currently in the money. An expiry date for these securities has not been disclosed. No quarterly cash balance or funding runway figure is available on record. No proposed securities issues are pending.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 31 Aug 2026 | 3H · cancellation | ACL : ORDINARY FULLY PAID | 186.5M | Appendix 3H |
| 31 Aug 2026 | 3G · unquoted | ORDINARY FULLY PAID | 186.5M | Appendix 3G |
| 31 Aug 2026 | 3G · unquoted | ACL : ORDINARY FULLY PAID | 186.5M | Appendix 3G |
| 20 July 2026 | 3G · unquoted | ORDINARY FULLY PAID | 186.5M | Appendix 3G |
| 29 June 2026 | 3G · unquoted | ACL : ORDINARY FULLY PAID | 186.5M | Appendix 3G |
Capital raises
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
No option supply on record carries an exercise price to pay, so no share price switches any of it on. All 3.0M of it converts on something else — a hurdle that may never be met, or terms the filing does not price.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| ACLAL | Performance rights | Condition-triggered | — | — | 1.2M | Filing Meeting |
| ACLAD | Rights | Condition-triggered | — | — | 1.8M | Filing Meeting |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.
A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 19 Feb 2026 | Sarah Butler | Buy on-market | 23k | — | — | $50k | 3Y notice |
| 28 Oct 2025 | Stephen Roche | Buy on-market | 70k | — | — | $194k | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 12 Sept 2026.